X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

INMB

Closed

Inmune Bio Inc

2.09
-0.22 (-9.52%)
Last Update: 01 Jul 2025 23:19:00
Yesterday: 2.31
Day's Range: 1.89 - 2.22
Send
When Written:
 
6.915
INmune Bio Inc is a clinical-stage biotechnology company that focuses on developing immunotherapies for the treatment of cancer and other diseases. The company's lead product candidate, INB03, is a novel biologic drug that targets a specific immune checkpoint molecule called CD47, which is overexpressed on many cancer cells and allows them to evade the immune system. INmune Bio is also developing a pipeline of other immunotherapies that target various aspects of the immune system, including cytokines, chemokines, and immune cells. The company was founded in 2015 and is headquartered in La Jolla, California.

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:216.73.216.11
X